Mostrar el registro sencillo del ítem

dc.contributor.authorCastaneda, Carlos A.
dc.date.accessioned2020-03-27T22:33:24Z
dc.date.available2020-03-27T22:33:24Z
dc.date.issued2018
dc.identifier.urihttps://hdl.handle.net/20.500.14308/2646
dc.description.abstractAim: Evaluation of features related to infiltrating immune cell level in glioblastoma. Methods: Tumor- infiltrating lymphocytes (TILs) through H&E staining, and TILs (CD3, CD4, CD8 and CD20) and macrophage (CD68 and CD163) levels through immunohistochemistry were evaluated through digital analysis. Results: CD68 (9.1%), CD163 (2.2%), CD3 (1.6%) and CD8 (1.6%) had the highest density. Higher CD4 + was as- sociated with unmethylated MGMT (p = 0.016). Higher CD8 + was associated with larger tumoral size (p = 0.027). Higher CD163 + was associated with higher age (p = 0.044) and recursive partitioning anal- ysis = 4. Women (p < 0.05), total resection (p < 0.05), MGMT-methylation (p < 0.001), radiotherapy (p < 0.001), chemotherapy (p < 0.001) and lower CD4 + (p < 0.05) were associated with longer overall survival. Conclusion: Macrophages are more frequent than TILs. Some subsets are associated with clinical features.es_PE
dc.formatapplication/pdfes_PE
dc.language.isoenges_PE
dc.publisherCNS Oncologyes_PE
dc.rightsinfo:eu-repo/semantics/openAccesses_PE
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.sourceUniversidad Privada San Juan Bautistaes_PE
dc.sourceRepositorio institucional - UPSJBes_PE
dc.subjectBiomarcadores_PE
dc.subjectGlioblastomaes_PE
dc.subjectMacrófagoses_PE
dc.subjectMGMTes_PE
dc.subjectSupervivencia generales_PE
dc.subjectPronósticoes_PE
dc.subjectInfiltración tumoral linfocitoses_PE
dc.titleDistribution of tumor-infiltrating immune cells in glioblastomaes_PE
dc.typeinfo:eu-repo/semantics/articlees_PE
dc.publisher.countryPE


Ficheros en el ítem

Thumbnail
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

info:eu-repo/semantics/openAccess
Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/openAccess